Oncology Archives - Seite 2 von 2 - CureVac

The regulatory landscape for actively personalized cancer immunotherapies

Developing mRNA-vaccine technologies

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

mRNA: delivering an antitumor message

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity

Intradermal Vaccinations With RNA Coding for TAA Generate CD8(+) and CD4(+) Immune Responses and Induce Clinical Benefit in Vaccinated Patients

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA

Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas